Table 1 Baselines characteristics of included studies
Reference | Country | Type | Age mean(SD) | Gender (Female, %) | Patients(n) | Left/Right | Stone size (mm) | SFR | Follow-up time | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Â | Â | Â | Group D | Group F | Group D | Group F | Group D | Group F | Group D | Group F | Group D | Group F | Â | Â |
Chen 2022 | China | cohort study | 53.23(12.68) | 53.95(13.57) | 101(67) | 100(66) | 150 | 150 | 81/69 | 84/66 | 51.33(58.69) a | 48.9(59.24a) |  ≤ 3 mm | 1 month |
El-Nahas 2019 | Kuwait | cohort study | 49.2 (13.2) | 50.5 (13.4) | 23(45) | 25(44) | 51 | 56 | 34/17 | 30/26 | 14.5 (5.5) | 14.4 (6.9) | NOR | 2Â month |
Golomb 2022 | Israel | cohort study | 53.5 (14.8) | 54 (13.3) | 16(32) | 21(42) | 50 | 50 | 30/17 | 26/24 | 17.0 (8.8) | 12.7 (5.4) |  ≤ 3 mm | Long term |
Humphreys 2018 | America | cohort study | 54.7 (13.0) | 53.9 (16.8) | 27(39) | 43(52) | 68 | 82 | 39/29 | 37/39 | 11.3 (4.3) | 8.8 (3.5) | NOR | 6Â week |
Lee 2016 | China | cohort study | 58.6(11.0) | 56.1(12.3) | 30(39) | 57(33) | 76 | 172 | NA | NA | 11.1(5.2) | 11.1(4.8) |  < 3 mm | 1 month |
Liao 2023 | China | RCT | 46.6(12.7) | 47.2(13.2) | 39(36) | 57(46) | 106 | 112 | 66/40 | 62/50 | 13.5 ± 3.8 | 14.3 ± 3.7 |  ≤ 2 mm | 3 month |
Mulåescu 2014 | Romania | cohort study | NA | NA | NA | NA | 40 | 40 | NA | NA | NA | NA |  ≤ 1 mm | 24 h |
Schatloff 2010 | Israel | RCT | 53.88(15.43) | 46.41(12.499) | 5(16) | 7(30) | 30 | 30 | NA | NA | 11.43(5.39) | 10.90(6.37) |  < 2 mm | 2 month |
Yildirim 2022 | Turkey | cohort study | 50.29(15.98) | 44.59(12.28) | 8(25) | 11(34) | 31 | 32 | 12/19 | 15/17 | 11.03(3.82) | 12.03(4.69) |  < 3 mm | 3 month |